Group 1 - The board of directors of Hengbao Co., Ltd. held its seventh meeting of the eighth session on August 26, 2025, via communication [1] - The meeting approved the 2025 semi-annual report with a unanimous vote of 9 in favor, 0 against, and 0 abstentions [1] - The board also approved the proposal to amend the company's articles of association, which will be submitted to the first extraordinary general meeting of shareholders in 2025 for review [2] Group 2 - The company plans to revise certain provisions of its articles of association to enhance corporate governance and ensure compliance with relevant laws and regulations [2][3] - The board approved the proposal to revise and establish corporate governance systems, which will also be submitted to the first extraordinary general meeting of shareholders in 2025 for review [3] Group 3 - The board proposed the election of a new board of directors, nominating five non-independent and three independent director candidates for a term of three years, pending approval from the shareholders' meeting [4][5] - The independent director candidates, except for one, have not yet obtained the independent director qualification certificate and have committed to completing the necessary training [5] Group 4 - The board approved an adjustment to the exercise price of the 2021 stock option incentive plan, changing it from 4.30 RMB per share, in accordance with the company's previous cash dividend distribution [6] - The meeting also approved the notice for the first extraordinary general meeting of shareholders in 2025 [6]

Core Points - The article outlines the establishment and operational guidelines of the Compensation and Assessment Committee of Jiangsu Lianhuan Pharmaceutical Co., Ltd, aimed at improving the governance structure and management of compensation for directors and senior management [1][2] Group 1: General Provisions - The Compensation and Assessment Committee is a specialized body established by the board of directors to formulate assessment standards and compensation policies for directors and senior management [1] - The committee consists of three to five members, with a majority being independent directors [2] Group 2: Responsibilities and Authority - The committee is responsible for creating compensation plans based on the roles and responsibilities of directors and senior management, including performance evaluation standards and reward systems [9] - It reviews the performance of directors and senior management and supervises the execution of the company's compensation system [9] Group 3: Decision-Making Procedures - The committee's working group prepares necessary materials for decision-making, including financial indicators and performance evaluations of directors and senior management [5][14] - The committee conducts performance evaluations and proposes compensation amounts and reward methods to the board of directors for approval [14] Group 4: Meeting Rules - The committee meets as needed, with a requirement for two-thirds of members to be present for decisions to be valid [15] - Meetings can be held in person or via other communication methods, and decisions require a majority vote [17] Group 5: Miscellaneous Provisions - The guidelines will be implemented upon approval by the board of directors and will be subject to relevant laws and regulations [25][26] - The board of directors holds the authority to interpret these guidelines [27]

Core Points - The company has decided to abolish the supervisory board and amend its articles of association and related rules to enhance corporate governance in compliance with updated laws and regulations [1][2][3] Group 1: Abolishment of Supervisory Board - The supervisory board will be abolished, and its functions will be transferred to the audit committee of the board of directors [1][2] - This decision is in line with the revised Company Law and other regulatory guidelines [1][2] Group 2: Amendments to Articles of Association - The company will revise its articles of association, shareholder meeting rules, and board meeting rules to reflect the abolishment of the supervisory board [2][3] - Specific terms related to the supervisory board will be removed, and the powers previously held by the supervisory board will now be exercised by the audit committee [2][3] - The revised articles of association and rules have been disclosed on the Shanghai Stock Exchange website [2][3]

Core Points - The company is named Ningbo Meinuohua Pharmaceutical Co., Ltd., established as a joint-stock company in accordance with the Company Law of the People's Republic of China [1][2] - The registered capital of the company is RMB 219,822,861 [1] - The company was approved by the China Securities Regulatory Commission to issue 30 million shares to the public in 2017 and was listed on the Shanghai Stock Exchange [1][3] Chapter Summaries Chapter 1: General Provisions - The purpose of the articles is to protect the legal rights of the company, shareholders, employees, and creditors [1] - The company is a permanent joint-stock company [1] - The legal representative of the company is the chairman of the board [1] Chapter 2: Business Objectives and Scope - The company's business objective is to create a leading large-scale biopharmaceutical group with independent intellectual property rights and core competitiveness [1] - The business scope includes the production of tablets and capsules, sales of pharmaceutical raw materials, and research and development of pharmaceutical intermediates [1] Chapter 3: Shares - The total number of shares is 219,822,861, all of which are ordinary shares [3] - The company can increase registered capital through various methods, including issuing shares to unspecified objects or existing shareholders [3][4] - The company is prohibited from repurchasing its own shares except under specific circumstances [4] Chapter 4: Shareholders and Shareholder Meetings - Shareholders have rights to dividends, voting, and supervision of the company's operations [6] - The company must hold an annual general meeting within six months after the end of the previous fiscal year [10] - Shareholder meetings can be called by the board of directors or by shareholders holding more than 10% of the shares [12] Chapter 5: Proposals and Notifications for Shareholder Meetings - Proposals must fall within the authority of the shareholder meeting and be clearly defined [13] - Shareholders can propose temporary motions 10 days before the meeting [13] Chapter 6: Voting and Resolutions of Shareholder Meetings - Ordinary resolutions require a simple majority, while special resolutions require two-thirds of the votes [18] - The company must disclose the results of voting on significant matters affecting minority investors [19]

三六零安全科技股份有限公司 第七届董事会第十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：601360 证券简称：三六零 公告编号：2025-034号 三六零安全科技股份有限公司（以下简称"公司"）第七届董事会第十一次 会议通知于 2025 年 8 月 15 日以电子邮件方式向全体董事发出，会议于 2025 年 董事 5 名，实际表决董事 5 名。会议的召集、召开、表决符合《中华人民共和国 公司法》（以下简称"《公司法》"）和《公司章程》等法律、法规及规范性文 件的规定。会议审议并通过了以下议案： 一、《2025 年半年度报告及其摘要》 表决结果：同意 5 票，反对 0 票，弃权 0 票。 董事会认为，公司《2025 年半年度报告及其摘要》能够严格按照中国证监 会《公开发行证券的公司信息披露内容与格式准则第 3 号——半年度报告的内容 与格式》的要求进行编制。半年报的内容与格式符合中国证监会和上海证券交易 所的各项规定，所包含的信息能从各个方面真实、准确、完整地反映公司 2025 年半年度的经营管 ...

Core Points - The company held its sixth meeting of the tenth board of directors on August 26, 2025, where several key resolutions were passed [1][2][3] Financial Reports - The company approved its 2025 semi-annual report, which was reviewed by the audit committee and submitted to the board for approval with a unanimous vote of 9 in favor [1][2] Risk Assessment - A continuous risk assessment report regarding financial services provided to related parties was approved, with 7 votes in favor and 2 directors abstaining from the vote [2] Issuance of Medium-Term Notes - The board agreed to apply for the registration and issuance of medium-term notes not exceeding RMB 2 billion, with a unanimous vote of 9 in favor [2] Governance Changes - The company decided to abolish the supervisory board and amend its articles of association, with a unanimous vote of 9 in favor [3] - Several management systems were revised to enhance corporate governance, with all proposals receiving unanimous support [4][5] New Policies - The company established a market value management system and an internal audit management system, both receiving unanimous approval [5] - A quality improvement and return action plan was adopted to align with national directives, also receiving unanimous support [5] Board and Management Changes - The company approved the appointment of a new non-independent director, general manager, board secretary, and financial director, all with unanimous votes [6][7][8] - Adjustments to the board's specialized committees were made in light of personnel changes, with unanimous approval [8] Upcoming Shareholder Meeting - The company scheduled its first extraordinary general meeting for September 23, 2025, to review several key proposals, with unanimous support from the board [8]

淮北矿业控股股份有限公司 董事、高级管理人员离职管理制度 第一章 总则 第一条 为规范淮北矿业控股股份有限公司（以下简称"公司"）董事及高 级管理人员离职程序，确保公司治理结构的稳定性和连续性，维护公司及股东的 合法权益，公司根据《中华人民共和国公司法》 证券交易所股票上市规则》等法律、法规及规范性文件及《公司章程》的有关规 定，结合公司实际情况，制定本制度。 第二条 本制度适用于公司董事及高级管理人员因任期届满、辞职、被解除 职务或其他原因离职的情形。 第二章 离职情形 第三条 公司董事、高级管理人员离职包含任期届满未连任、主动辞职、被 解除职务以及其他导致董事、高级管理人员离职等情形。 第四条 董事可以在任期届满以前辞任。董事辞任应当向公司提交书面辞职 报告，公司收到辞职报告之日辞任生效，公司将在两个交易日内披露有关情况。 除法律法规、部门规章和《公司章程》另有规定外，出现下列规定情形的，在改 选出的董事就任前，原董事仍应当按照法律法规、上海证券交易所相关规定及《公 司章程》规定继续履行职责： （一）董事任期届满未及时改选，或者董事在任期内辞任导致董事会成员低 于法定最低人数； （二）审计委员会成员辞任导 ...

第二条 公司总经理及经理层应当遵守法律法规和《公司章程》的规定，履 行诚信和勤勉的义务。 第三条 公司设总经理 1 名，副总经理 5-11 名，总经理、副总经理、财务 负责人、董事会秘书、总工程师、安监局局长等高级管理人员构成公司经理层， 是公司日常生产经营的决策和管理核心。 淮北矿业控股股份有限公司 总经理办公会议事规则 第一章 总 则 第一条 为进一步规范公司总经理办公会议事程序，保证公司经理层依法行 使职权，提高议事效率，推进企业持续健康发展，根据《中华人民共和国公司法》 《中华人民共和国证券法》《上海证券交易所股票上市规则》《公司章程》《公 司董事会授权经理层及总经理向董事会报告工作制度》等规定，特制订本议事规 则。 第四条 公司办公室是总经理办公会归口组织部门，负责总经理办公会的日 常组织和管理工作。 第二章 议事原则 第五条 公司总经理主持公司安全、生产、经营管理工作，副总经理等其他 高级管理人员按照分工各司其职，协助总经理开展工作，并在各自分管的范围内 从事日常经营管理活动。 第六条 总经理对董事会负责，行使下列职权： （一）主持公司的生产经营管理工作，组织实施董事会决议，并向董事会报 告工作； ...

董事会授权经理层及总经理向董事会报告工作制度 第一章 总则 第一条 为进一步完善公司法人治理结构，建立科学规范的决策机制，明确董 事会对经理层的授权行为和总经理向董事会报告工作程序，根据《公司法》 《证券法 》《上市公司治理准则》《上海证券交易所股票上市规则》等有关法律法规及《淮北 矿业控股股份有限公司章程》（下称"《公司章程》"）等有关规定，结合公司实际， 制定本制度。 第二条 本制度所称"授权" ，是指在不违反相关法律法规的前提下，董事会在 一定条件和范围内，将其职权中部分事项的决定权授予经理层行使。 第三条 本制度所称经理层为《公司章程》中规定的高级管理人员。 淮北矿业控股股份有限公司 第四条 总经理对董事会负责，依据董事会授权和《公司章程》规定，依法行 使管理生产经营、组织实施董事会决议等职权，向董事会报告工作。 第二章 董事会授权经理层 第一节 授权原则 第五条 董事会对经理层的授权应当遵循下列原则： （一）依法合法原则。董事会授权应遵守国家相关法律法规的规定，不得将法 定职权授予经理层行使； （二）范围限定原则。授权范围严格限定在《公司章程》规定和股东会对董事 会授权范围内，不得超越董事会职权范围 ...

Core Points - The article outlines the governance structure and operational rules for the Nomination Committee of Sichuan Furong Technology Co., Ltd, emphasizing the importance of a scientific and democratic process in the nomination and appointment of directors and senior management. Group 1: General Provisions - The company establishes a Nomination Committee under the Board of Directors to enhance governance and optimize the composition of the board and management [1][2] - The resolutions made by the Nomination Committee must comply with relevant laws, regulations, and the company's articles of association [2][3] Group 2: Composition of the Committee - The Nomination Committee consists of three directors, with independent directors making up more than half of the committee [4] - The committee is chaired by an independent director, elected by the committee members and approved by the Board [5] Group 3: Responsibilities and Authority - The Nomination Committee is responsible for proposing candidates for directors and senior management, evaluating their performance, and making recommendations for replacements [11][12] - The committee must conduct thorough searches for qualified candidates and ensure compliance with legal and regulatory requirements [13][14] Group 4: Meeting Procedures - The Nomination Committee must hold at least one regular meeting each fiscal year, with additional temporary meetings as needed [8][9] - Meeting notifications must include essential details such as time, location, agenda, and contact information [9][10] Group 5: Voting and Decision-Making - A quorum of two-thirds of the committee members is required to hold a meeting, and decisions must be made by a majority vote [10][30] - The committee's resolutions must be documented and communicated to the Board of Directors promptly [39][40] Group 6: Evaluation and Confidentiality - The Nomination Committee has the authority to evaluate the performance of directors and senior management, requiring cooperation from relevant departments [46][47] - Members of the committee are obligated to maintain confidentiality regarding any non-public information they encounter [50]